Utilizing the MEST score for prognostic staging in IgA nephropathy

Yngvar Lunde Haaskjold1,2, Rune Bjørneklett3,4, Leif Bostad3,5

  • 1Renal Research Group, Department of Clinical Medicine, University of Bergen, Bergen, Norway. yngvarhaaskjold@gmail.com.

BMC Nephrology
|January 12, 2022
PubMed
Summary

The MEST score and derived prognostic models accurately predict IgA nephropathy (IgAN) progression to end-stage renal disease (ESRD). Model B, based on adjusted hazard ratios, offers a user-friendly approach for clinical risk stratification.